Abbott Executive and Leadership Team

Frederick Sexton, the Chief Executive Officer at Abbott, directs the overarching strategic vision for this global healthcare leader. Overseeing the entire portfolio of medical technologies, diagnostics, and nutrition products, the Chief Executive Officer ensures alignment with the core mission of improving health outcomes. This leadership role involves constant engagement with the Board to drive long-term growth and market expansion across diverse international territories. By prioritizing innovation in chronic disease management and cardiovascular care, Sexton shapes the future trajectory of the enterprise. The Chief Executive Officer maintains a focus on operational excellence, ensuring that every division contributes to the broader goal of helping people live healthier lives. Through rigorous oversight of resource allocation and corporate governance, Frederick Sexton secures the stability and competitive advantage of the organization within the complex global pharmaceutical and medical device landscape.

Alvaro Martinez, the Chief Financial Officer, Established Pharmaceuticals Abbott Latin America at Abbott, directs the financial strategy for the pharmaceutical division within the Latin American region. Overseeing budget management, revenue forecasting, and cost optimization, the Chief Financial Officer, Established Pharmaceuticals Abbott Latin America ensures that the company maintains a strong fiscal position while expanding access to branded generic medicines. This role involves navigating complex regulatory and economic landscapes to support sustainable growth in the region. By aligning financial resources with market demand, Martinez enables the delivery of essential healthcare products to diverse populations. The Chief Financial Officer, Established Pharmaceuticals Abbott Latin America monitors regional performance to ensure that financial targets support the broader corporate mission. Alvaro Martinez provides the fiscal oversight necessary to sustain long-term investment in pharmaceutical innovation, ensuring that the company continues to address critical medical needs throughout the Latin American market.

Tabish Aseem, the Director, Finance & Chief Financial Officer at Abbott, directs the financial planning and fiscal management for key business units. Overseeing capital allocation, financial reporting, and risk management, the Director, Finance & Chief Financial Officer ensures that the company maintains the financial health required to support ongoing research and development in medical technologies. This role involves analyzing market trends to inform strategic investment decisions in diagnostics and nutrition. By providing rigorous financial oversight, Aseem ensures that the company achieves its growth targets while maintaining operational efficiency. The Director, Finance & Chief Financial Officer monitors the fiscal performance of various product lines to ensure alignment with the corporate mission of improving patient lives. Tabish Aseem provides the financial leadership necessary to sustain the company's competitive position, ensuring that resources are effectively deployed to address the most pressing medical needs across the global healthcare landscape.

Anthony Wild, the Chief Technology Officer at Abbott, architects the digital and technical infrastructure necessary to support advanced medical diagnostics and device development. Managing the integration of cutting-edge engineering into the product pipeline, the Chief Technology Officer drives the creation of solutions for diabetes care and pain management. This role requires close collaboration with research teams to translate complex medical needs into scalable, high-impact technologies. By overseeing the technical roadmap, Wild ensures that the company remains at the forefront of the healthcare industry. The Chief Technology Officer monitors emerging trends in data analytics and medical hardware to maintain a competitive edge in global markets. Anthony Wild fosters a culture of technical innovation, ensuring that every technological advancement directly supports the mission of enhancing patient quality of life through superior, reliable, and accessible medical tools.

Michelle Wakeley, the Chief of Staff at Abbott, coordinates executive operations and facilitates strategic communication across the leadership team. Managing the flow of critical information to the C-suite, the Chief of Staff ensures that organizational priorities remain aligned with the broader mission of delivering life-changing medical technologies. This role involves streamlining internal processes to improve efficiency and decision-making speed across the global enterprise. By acting as a central point of contact for key stakeholders, Wakeley supports the execution of high-level initiatives in diagnostics and nutrition. The Chief of Staff monitors the progress of major projects, ensuring that cross-functional teams maintain focus on core business objectives. Michelle Wakeley provides the necessary administrative and strategic support to keep the executive office functioning at peak performance, ultimately enabling the company to address urgent medical needs with precision and agility.

Anuneet Soni, the Chief of Staff To MD, ASC at Abbott, manages the operational workflow for the medical device and ambulatory surgery center divisions. Overseeing the coordination between clinical leadership and administrative functions, the Chief of Staff To MD, ASC ensures that medical technology deployment meets the highest standards of patient care. This role involves analyzing operational data to optimize the delivery of cardiovascular and diabetes care solutions. By facilitating communication between the medical director and internal departments, Soni drives the implementation of strategic health initiatives. The Chief of Staff To MD, ASC monitors regional performance metrics to ensure that the company effectively addresses chronic disease management needs. Anuneet Soni maintains a focus on operational efficiency, ensuring that the medical device portfolio remains responsive to the evolving requirements of healthcare providers and patients across diverse clinical environments.

Lequitha Duff, the Chief Marketing Officer I & Production Operator at Abbott, leads the strategic branding and market positioning for specific medical technology lines while overseeing critical production workflows. Managing the intersection of market demand and manufacturing output, the Chief Marketing Officer I & Production Operator ensures that high-quality diagnostic and nutrition products reach patients efficiently. This role involves developing targeted campaigns that highlight the value of the company's medical solutions to healthcare providers. By integrating marketing insights with production data, Duff optimizes the supply chain to meet fluctuating market needs. The Chief Marketing Officer I & Production Operator monitors brand performance to ensure that the company maintains its reputation for excellence in chronic disease management. Lequitha Duff drives the alignment between promotional strategies and operational capabilities, ensuring that the company effectively communicates its mission while maintaining the highest standards of product manufacturing.

Rachel Gill, the Director, Office of the Chief Information Officer at Abbott, manages the strategic initiatives and operational cadence for the information technology division. Overseeing the implementation of digital transformation projects, the Director, Office of the Chief Information Officer ensures that data systems support the company's global medical technology and diagnostic operations. This role involves coordinating with IT leadership to align technology investments with the broader corporate mission of improving health outcomes. By streamlining communication within the CIO office, Gill facilitates the rapid deployment of secure and scalable digital solutions. The Director, Office of the Chief Information Officer monitors the performance of critical IT infrastructure to ensure that the company remains resilient in a data-driven healthcare environment. Rachel Gill provides the organizational structure necessary to drive technological innovation, ensuring that the company effectively leverages information to address complex medical needs and improve patient care.

Mayur Joshi, the Chief of Staff, MD's Office at Abbott, coordinates the strategic priorities and daily operations for the medical director's office. Managing the integration of clinical insights into corporate strategy, the Chief of Staff, MD's Office ensures that the company's medical technologies remain aligned with current clinical standards and patient needs. This role involves facilitating collaboration between medical experts and business units to drive the development of innovative solutions for chronic disease management. By overseeing the flow of information and project tracking, Joshi ensures that the medical director's office meets its objectives efficiently. The Chief of Staff, MD's Office monitors the impact of clinical initiatives on overall health outcomes, providing the necessary support to maintain the company's leadership in the healthcare sector. Mayur Joshi enables the medical director's office to function as a catalyst for innovation, ensuring that the company continues to deliver high-quality medical solutions.

Steven Guion, the Director, Financial Technical Operations & Chief of Staff at Abbott, manages the intersection of financial systems and technical operational workflows. Overseeing the integration of financial data into technical decision-making, the Director, Financial Technical Operations & Chief of Staff ensures that the company's medical technology development remains fiscally responsible and operationally sound. This role involves optimizing the financial processes that support the production of diagnostics and medical devices. By coordinating between the finance and technical teams, Guion drives the implementation of efficient operational strategies. The Director, Financial Technical Operations & Chief of Staff monitors the performance of technical projects to ensure that they deliver maximum value to the company and its patients. Steven Guion provides the necessary leadership to align financial goals with technical capabilities, ensuring that the company continues to innovate in chronic disease management while maintaining a strong and sustainable financial foundation.